Teva Pharmaceutical Industries Ltd TEVA reported a 6.7% rise in its first-quarter net income. The company also affirmed its projections for the full year.
The company's profit increased to $761 million, or $0.84 per share, versus $713 million, or $0.79 per share, in the year-ago period. The company's adjusted net rose to $1.04 per share from $0.91 per share. The company's shares outstanding dropped 2.1% to 902 million. Its sales climbed 12% to $4.08 billion. However, analysts were expecting earnings of $1.04 per share on sales of $4.28 billion. TEVA's sales in Europe increased 66% while sales in North America dropped 11%.
TEVA projects 2011 adjusted earnings of $4.90 to $5.20 per share on revenue of $18.5 billion to $19 billion. However, analysts were projecting earnings of $5.07 per share on revenue of $18.74 billion.
TEVA shares gained 0.32% to $47.29 in after-hours trading.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in